HR4475

This bill, HR4475, amends Section 1834(h)(1) of the Social Security Act to prohibit Medicare payment for orthotics and prosthetics delivered via drop shipment without prior training or education from a qualified practitioner. It also amends Section 1847(a)(7)(A)(i) to exempt physical therapists, occupational therapists, orthotists, and prosthetists from competitive acquisition requirements. This directly impacts the supply chain for orthotics and prosthetics, eliminating a low-cost, low-service delivery model and favoring providers who offer in-person fitting and patient education. The bill is in early stages, referred to two committees, but its provisions are clear and actionable. The money trail shifts from direct-to-consumer, potentially fraudulent, drop-shipped products to qualified practitioners and established providers. Companies with robust networks of certified orthotists and prosthetists, and those manufacturing high-quality, custom-fitted devices, stand to gain. The elimination of drop shipments reduces competition from unqualified providers and ensures that Medicare funds are directed towards professional, patient-centered care. While no specific dollar amounts are appropriated, the redirection of existing Medicare spending on orthotics and prosthetics will benefit compliant providers. Historically, legislative efforts to curb Medicare fraud and ensure quality of care in medical device sectors have led to consolidation and increased market share for established, compliant players. For example, in 2013, CMS implemented stricter rules for Durable Medical Equipment (DME) suppliers, leading to a shake-out of smaller, non-compliant providers and benefiting larger, reputable companies. While specific stock movements from that period are difficult to isolate due to broader market conditions, the trend favored companies with strong compliance infrastructure. This bill mirrors that intent by tightening delivery standards and professional requirements. Specific winners include companies like Hanger Inc. (parent company of $HAE), which operates a large network of orthotic and prosthetic patient care centers and manufactures devices. Össur hf. ($OSUR), a global leader in non-invasive orthopaedics, and Ottobock (parent company of $OTTR), a private company but a major industry player, will also benefit from increased demand for professionally fitted products and reduced competition from unqualified sources. Companies that relied heavily on drop-shipping models or supplied such operations will lose market share. The bill's sponsors include senior members like Rep. Thompson of Pennsylvania, indicating moderate legislative momentum. Next, the bill will undergo committee review. If it passes committee, it will move to a floor vote. Given its focus on patient protection and fraud reduction, it has a reasonable chance of passage. The earliest this bill could become law is late 2025 or early 2026, with implementation likely taking effect in 2027.